Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors

被引:194
作者
Haan, Claude [1 ]
Rolvering, Catherine [1 ]
Raulf, Friedrich [2 ]
Kapp, Manuela [2 ]
Drueckes, Peter [2 ]
Thoma, Gebhard [2 ]
Behrmann, Iris [1 ]
Zerwes, Hans-Guenter
机构
[1] Univ Luxembourg, Signal Transduct Lab, Life Sci Res Inst, L-1511 Luxembourg, Luxembourg
[2] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland
来源
CHEMISTRY & BIOLOGY | 2011年 / 18卷 / 03期
关键词
SEVERE COMBINED IMMUNODEFICIENCY; ACUTE MEGAKARYOBLASTIC LEUKEMIA; JANUS KINASES; INTERLEUKIN-2; RECEPTOR; BETA-CHAIN; TYROSINE PHOSPHORYLATION; LYMPHOID DEVELOPMENT; INHIBITOR CP-690550; CHEMICAL GENETICS; JAK/STAT PATHWAY;
D O I
10.1016/j.chembiol.2011.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (gamma c) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression. Jak1 cooperates with Jak3 in signaling through gamma c-containing receptors. Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors. We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system. The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation. Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor. Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.
引用
收藏
页码:314 / 323
页数:10
相关论文
共 58 条
[1]
The interleukin (IL)-2 family cytokines: Survival and proliferation signaling pathways in T lymphocytes [J].
Benczik, M ;
Gaffen, SL .
IMMUNOLOGICAL INVESTIGATIONS, 2004, 33 (02) :109-142
[2]
Unnatural ligands for engineered proteins: New tools for chemical genetics [J].
Bishop, A ;
Buzko, O ;
Heyeck-Dumas, S ;
Jung, I ;
Kraybill, B ;
Liu, Y ;
Shah, K ;
Ulrich, S ;
Witucki, L ;
Yang, F ;
Zhang, C ;
Shokat, KM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :577-606
[3]
Magic bullets for protein kinases [J].
Bishop, AC ;
Buzko, O ;
Shokat, KM .
TRENDS IN CELL BIOLOGY, 2001, 11 (04) :167-172
[4]
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog [J].
Boggon, TJ ;
Li, YQ ;
Manley, PW ;
Eck, MJ .
BLOOD, 2005, 106 (03) :996-1002
[5]
JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants [J].
Borie, DC ;
O'Shea, JJ ;
Changelian, PS .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (11) :532-541
[6]
Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain [J].
Cacalano, NA ;
Migone, TS ;
Bazan, F ;
Hanson, EP ;
Chen, M ;
Candotti, F ;
O'Shea, JJ ;
Johnston, JA .
EMBO JOURNAL, 1999, 18 (06) :1549-1558
[7]
PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity [J].
Cameron, Angus J. M. ;
Escribano, Cristina ;
Saurin, Adrian T. ;
Kostelecky, Brenda ;
Parker, Peter J. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (06) :624-U57
[8]
DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN [J].
CAO, XQ ;
SHORES, EW ;
HULI, J ;
ANVER, MR ;
KELSALL, BL ;
RUSSELL, SM ;
DRAGO, J ;
NOGUCHI, M ;
GRINBERG, A ;
BLOOM, ET ;
PAUL, WE ;
KATZ, SI ;
LOVE, PE ;
LEONARD, WJ .
IMMUNITY, 1995, 2 (03) :223-238
[9]
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].
Changelian, PS ;
Flanagan, ME ;
Ball, DJ ;
Kent, CR ;
Magnuson, KS ;
Martin, WH ;
Rizzuti, BJ ;
Sawyer, PS ;
Perry, BD ;
Brissette, WH ;
McCurdy, SP ;
Kudlacz, EM ;
Conklyn, MJ ;
Elliott, EA ;
Koslov, ER ;
Fisher, MB ;
Strelevitz, TJ ;
Yoon, K ;
Whipple, DA ;
Sun, JM ;
Munchhof, MJ ;
Doty, JL ;
Casavant, JM ;
Blumenkopf, TA ;
Hines, M ;
Brown, MF ;
Lillie, BM ;
Subramanyam, C ;
Shang-Poa, C ;
Milici, AJ ;
Beckius, GE ;
Moyer, JD ;
Su, CY ;
Woodworth, TG ;
Gaweco, AS ;
Beals, CR ;
Littman, BH ;
Fisher, DA ;
Smith, JF ;
Zagouras, P ;
Magna, HA ;
Saltarelli, MJ ;
Johnson, KS ;
Nelms, LF ;
Des Etages, SG ;
Hayes, LS ;
Kawabata, TT ;
Finco-Kent, D ;
Baker, DL ;
Larson, M .
SCIENCE, 2003, 302 (5646) :875-878
[10]
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains [J].
Chen, M ;
Cheng, A ;
Candotti, F ;
Zhou, YJ ;
Hymel, A ;
Fasth, A ;
Notarangelo, LD ;
O'Shea, JJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) :947-956